![](/img/cover-not-exists.png)
Neoadjuvant Nab -paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX
PETERSON, SHAWN L., HUSNAIN, MUHAMMAD, POLLACK, TERRI, PIMENTEL, AGUSTIN, LOAIZA-BONILLA, ARTURO, WESTENDORF-OVERLEY, COLLEEN, RATERMANN, KELLEY, ANTHONY, LOWELL, DESIMONE, PHILIP, GOEL, GAURAV, KUDRIVolume:
38
Language:
english
Journal:
Anticancer Research
DOI:
10.21873/anticanres.12692
Date:
July, 2018
File:
PDF, 88 KB
english, 2018